Patent details

EP3134438 Title: IGF-1R ANTIBODY AND ITS USE AS ADDRESSING VEHICLE FOR THE TREATMENT OF CANCER

Basic Information

Publication number:
EP3134438
PCT Application Number:
EP2015059050
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP157278847
PCT Publication Number:
WO2015162292
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
IGF-1R ANTIBODY AND ITS USE AS ADDRESSING VEHICLE FOR THE TREATMENT OF CANCER
French Title of Invention:
ANTICORPS IGF-1R ET SON UTILISATION COMME VÉHICULE D'ADRESSAGE POUR LE TRAITEMENT DU CANCER
German Title of Invention:
IGF-1R-ANTIKÖRPER UND DESSEN VERWENDUNG ALS ADRESSIERUNGSMEDIUM BEI DER BEHANDLUNG VON KREBS
SPC Number:

Dates

Filing date:
27/04/2015
Grant date:
30/09/2020
EP Publication Date:
01/03/2017
PCT Publication Date:
29/10/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
30/09/2020
EP B1 Publication Date:
30/09/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
27/04/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
23/09/2020
 
 

Name:
Pierre Fabre Médicament
Address:
45, Place Abel Gance, 92100 Boulogne-Billancourt, France (FR)

Agent

Name:
REGIMBEAU
From:
17/12/2020
Address:
RUE DE CHAZELLES 20, 75847, PARIS CEDEX 17, France (FR)
To:

Inventor

1

Name:
CHAMPION, Thierry
Address:
France (FR)

2

Name:
GOETSCH, Liliane
Address:
France (FR)

3

Name:
ROBERT, Alain
Address:
France (FR)

4

Name:
BEAU-LARVOR, Charlotte
Address:
France (FR)

5

Name:
BROUSSAS, Matthieu
Address:
France (FR)

Priority

Priority Number:
201461984160 P
Priority Date:
25/04/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61P 35/00; C07K 16/28; A61K 47/68;

Publication

European Patent Bulletin

1

Issue number:
202040
Publication date:
30/09/2020
Description:
Grant (B1)

2

Issue number:
202045
Publication date:
04/11/2020
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
30/04/2026
Annual Fee Number:
12
Annual Fee Amount:
165 Euro
Expected Payer:
Last Annual Fee Payment Date:
24/03/2025
Last Annual Fee Paid Number:
11
Last Annual Fee Paid Amount:
148 Euro
Payer:
ACUMASS SARL
Filing date Document type Number of pages
18/12/2020 Power Of Attorney 2
22/12/2020 Outgoing Correspondence 1